Metabolic Syndrome
Metabolic Syndrome(代谢综合征)
Metabolic Syndrome 相关产品(21)
- GC44062L-hydroxy Arginine (acetate)CAS: 1140844-61-6纯度: >95.00%
A substrate for nitric oxide synthase
- GC45126Uric Acid (sodium salt) (Standard)CAS: 1198-77-2纯度: >99.50%
An end product of purine metabolism
- GC45779Palmitic Acid-13C (C1 labeled)CAS: 57677-53-9纯度: >98.00%
An internal standard for the quantification of palmitic acid
- GC45976Palmitic Acid-13C (C2 labeled)CAS: 287100-87-2纯度: >95.00%
An internal standard for the quantification of palmitic acid
- GC47859Palmitic Acid-13C (C1, C2, C3, and C4 labeled)CAS: 287100-89-4纯度: >98.00%
An internal standard for the quantification of palmitic acid
- GC47860Palmitic Acid-d2CAS: 62689-96-7纯度: >99.00%
An internal standard for the quantification of palmitic acid
- GC47861Palmitic Acid-d31CAS: 39756-30-4纯度: >99.00%
An internal standard for the quantification of palmitic acid
- GC47862Palmitic Acid-d5CAS: 285979-77-3纯度: >99.00%
An internal standard for the quantification of palmitic acid
- GC49373L-Alanine-d3CAS: 63546-27-0纯度: >98.00%
An internal standard for the quantification of L-alanine
- GC91977TrkB Agonist Prodrug R13CAS: 1609067-49-3纯度: >95.00%
TrkB Agonist Prodrug R13（R13）是原肌球蛋白相关激酶B（TrkB）激活剂7,8-二羟基黄酮的前药形式。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18870 | 6-NBDG | 108708-22-1 | >98.00% | |
A non-hydrolyzable fluorescent glucose analog | ||||
| GC42795 | Amylin (human) (amidated) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC44062 | L-hydroxy Arginine (acetate) | 1140844-61-6 | >95.00% | |
A substrate for nitric oxide synthase | ||||
| GC44943 | sPLA2 Inhibitor | 393569-31-8 | >95.00% | |
An orally active inhibitor of sPLA 2 -IIA | ||||
| GC45126 | Uric Acid (sodium salt) (Standard) | 1198-77-2 | >99.50% | |
An end product of purine metabolism | ||||
| GC45469 | Hexacosanoic Acid-d4 | 1208837-79-9 | >99.00% | |
| ||||
| GC45779 | Palmitic Acid-13C (C1 labeled) | 57677-53-9 | >98.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC45976 | Palmitic Acid-13C (C2 labeled) | 287100-87-2 | >95.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC47859 | Palmitic Acid-13C (C1, C2, C3, and C4 labeled) | 287100-89-4 | >98.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC47860 | Palmitic Acid-d2 | 62689-96-7 | >99.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC47861 | Palmitic Acid-d31 | 39756-30-4 | >99.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC47862 | Palmitic Acid-d5 | 285979-77-3 | >99.00% | |
An internal standard for the quantification of palmitic acid | ||||
| GC48196 | trans-Vaccenic Acid-d13 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48418 | N-(2-Poc-ethyl)betulin amide | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC48449 | 28-(Poc-amino)betulin | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC49024 | Palmitic Acid MaxSpec® Standard | 57-10-3 | >95.00% | |
A long-chain saturated fatty acid | ||||
| GC49176 | 5β-Tetrahydrocortisol | 53-02-1 | >97.00% | |
An endogenous metabolite of cortisol | ||||
| GC49373 | L-Alanine-d3 | 63546-27-0 | >98.00% | |
An internal standard for the quantification of L-alanine | ||||
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
一种皮质醇的代谢产物。 | ||||
| GC91977 | TrkB Agonist Prodrug R13 | 1609067-49-3 | >95.00% | |
TrkB Agonist Prodrug R13（R13）是原肌球蛋白相关激酶B（TrkB）激活剂7,8-二羟基黄酮的前药形式。 | ||||